TCTMD

SPYRAL HTN-ON MED Trial of Renal Denervation Misses Primary Endpoint

CHICAGO, IL—In the expanded SPYRAL HTN-ON MED trial, renal denervation with the Symplicity Spyral multielectrode catheter (Medtronic) failed to meet its primary endpoint in terms of blood ...
TCTMD

SPYRAL HTN-ON MED at 3 Years: Renal Denervation’s BP Impact Endures

WASHINGTON, DC—In patients treated with antihypertensive medication, renal denervation using the Symplicity Spyral radiofrequency catheter (Medtronic) provides additional reductions in blood pressure ...
Healio

FDA approves second renal denervation device to treat hypertension

Please provide your email address to receive an email when new articles are posted on . The FDA approved a radiofrequency renal denervation device for treatment of hypertension. An FDA advisory panel ...